To demonstrate that Hyper-IL-6 was able to function in PDT-treated cells independently of the membrane IL-6Rα, the IL-6R-null C33A tumour cell line was subjected to the same PDT treatment as HeLa cells. The gene discussed is IL6R; the disease is neoplasm.